Characterization of prenylated protein methyltransferase in Leishmania

M P Hasne1, F Lawrence

  • 1Centre National de la Recherche Scientifique, Institut de Chimie des Substances Naturelles, Avenue de la Terrasse, 91 198 Gif-sur-Yvette Cedex, France.

The Biochemical Journal
|September 8, 1999
PubMed

Insights

Prenylated protein methyltransferase in Leishmania donovani modifies signaling proteins. This enzyme preferentially methylates farnesylated substrates, unlike mammalian enzymes, impacting protein carboxymethylation.

Area of Science:

  • Biochemistry
  • Parasitology
  • Molecular Biology

Background:

  • Prenylated protein methyltransferase is crucial for post-translational modification of signaling proteins.
  • Leishmania donovani is a parasitic protozoan with unique biological pathways.

Purpose of the Study:

  • To characterize the prenylated protein methyltransferase in Leishmania donovani.
  • To investigate the enzyme's substrate specificity and regulatory mechanisms.

Main Methods:

  • Enzyme activity assay using S-adenosyl-l-[methyl-(3)H]methionine and an S-prenylated cysteine analogue.
  • Analysis of endogenous substrates and the effect of specific treatments on protein carboxymethylation.

Main Results:

  • The enzyme is primarily membrane-associated (>85% activity).
  • Leishmania enzyme shows higher affinity for N-acetyl-S-trans,trans-farnesyl-l-cysteine than N-acetyl-S-all-trans-geranylgeranyl-l-cysteine, differing from mammalian enzymes.
  • Endogenous substrates are isoprenylated and carboxymethylated, with specific molecular masses identified.
  • Cellular treatment affected protein carboxymethylation levels.

Conclusions:

  • Leishmania donovani possesses a distinct prenylated protein methyltransferase with unique substrate preferences.
  • This enzyme plays a role in the carboxymethylation of isoprenylated proteins in Leishmania.
  • Understanding this enzyme may offer insights into parasitic biology and potential drug targets.